Adaptive Biotechnologies Corporation

ADPT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$47,920$65,064$90,030$139,065
Short-Term Investments$174,374$281,337$408,166$213,996
Receivables$41,731$37,969$40,057$17,409
Inventory$8,440$14,448$14,453$19,263
Other Curr. Assets$11,287$11,370$9,440$13,015
Total Curr. Assets$283,752$410,188$562,146$402,748
Property Plant & Equip (Net)$94,383$120,323$164,210$172,940
Goodwill$118,972$118,972$118,972$118,972
Intangibles$3,425$5,128$6,827$8,526
Long-Term Investments$33,660$0$0$217,145
Tax Assets$0$0$0$0
Other NC Assets$5,184$6,523$4,462$3,013
Total NC Assets$255,624$250,946$294,471$520,596
Other Assets$0$0$0$0
Total Assets$539,376$661,134$856,617$923,344
Liabilities
Payables$7,265$7,719$8,084$3,307
Short-Term Debt$10,239$9,384$9,230$5,055
Tax Payable$176$59$194$391
Deferred Revenue$55,689$48,630$64,115$80,460
Other Curr. Liab.$24,684$22,223$28,165$24,594
Total Curr. Liab.$98,053$88,015$109,788$113,807
LT Debt$79,148$89,388$98,772$106,685
Deferred Rev, NC$27,256$44,793$58,599$98,750
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$132,434$130,660$125,360$0
Total NC Liab.$238,838$264,841$282,731$205,435
Other Liabilities$0$0$0$0
Cap. Leases$89,387$98,772$108,002$111,740
Total Liabilities$336,891$352,856$392,519$319,242
Equity
Pref Stock$0$0$0$0
Common Stock$14$14$14$14
Retained Earnings-$1,303,824-$1,144,332-$919,082-$718,891
AOCI$166$215-$4,116-$1,137
Other Equity$1,506,353$1,452,502$1,387,349$1,324,006
Total Equity$202,709$308,399$464,165$603,992
Supplemental Information
Minority Interest-$224-$121-$67$110
Total Liab. & Tot. Equity$539,376$661,134$856,617$923,344
Net Debt$41,467$33,708$17,972-$27,325
Adaptive Biotechnologies Corporation (ADPT) Financial Statements & Key Stats | AlphaPilot